About DecodeMyBio

Our Mission

DecodeMyBio exists to make pharmacogenomic information accessible. Millions of people have DNA raw data from consumer testing services like 23andMe and AncestryDNA. That data contains clinically relevant genetic variants that influence how individuals metabolize medications — but most people never see those insights.

We bridge that gap by analyzing raw genotype data against established clinical pharmacogenomics guidelines, producing reports that individuals can review and share with their healthcare providers. Explore our learning center to understand how pharmacogenomics works and what your results mean.

What We Do

DecodeMyBio accepts raw DNA data files and extracts clinically relevant pharmacogenomic variants. We map those variants to star alleles, determine diplotypes and metabolizer phenotypes, and cross-reference the results against drug-gene interaction guidelines published by the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Dutch Pharmacogenetics Working Group (DPWG). For a step-by-step explanation, see how pharmacogenomic testing works. Read our methodology for a detailed walkthrough of each step.

The result is a Medication Safety Report that identifies potential drug-gene interactions for medications where pharmacogenomic evidence exists at CPIC Level A or B. You can preview a sample report to see the format. If you are comparing approaches to pharmacogenomic testing, see how DecodeMyBio compares to clinician-ordered panels or read our cost comparison breakdown.

Scientific Foundation

Our analysis pipeline is built on peer-reviewed pharmacogenomics data and clinical guidelines. We do not make proprietary claims or use unpublished algorithms. Every finding in a DecodeMyBio report traces back to published clinical guidelines, primarily from CPIC and DPWG, with allele definitions from PharmVar and variant annotations from FDA-recognized pharmacogenomic biomarkers. See our data sources page for the full list.

What We Are Not

DecodeMyBio is not a medical device, diagnostic tool, or healthcare provider. Our reports are informational and intended to supplement — not replace — clinical judgment. Users should always consult their healthcare provider before making any medication changes based on pharmacogenomic information. For a full discussion, see our limitations page.

Editorial Policy

All content on DecodeMyBio is reviewed by the DecodeMyBio Editorial Team. We reference only peer-reviewed sources and established clinical guidelines. Content is updated when CPIC or DPWG release new or revised guidelines. Read our full editorial policy for details on our evidence standards, review process, and corrections policy.

Contact

For questions, feedback, or data deletion requests, contact us at support@decodemybio.com.